80180 Drug screening quan mycophenolate
Also known as: mycophenolate level, immunosuppressant level
Laboratory quantitative drug screen for mycophenolate to assess serum level for therapeutic drug monitoring in immunosuppression and transplantation.
In Plain Language
mycophenolate blood test; transplant medication level
Clinical Context
Monitors mycophenolic acid (mycophenolate metabolite) levels in transplant recipients for optimal immunosuppression and reduced rejection risk.
RVU Information
CPT 80180 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 80180?
CPT 80180 (Drug screening quan mycophenolate) is a Pathology & Lab code. Laboratory quantitative drug screen for mycophenolate to assess serum level for therapeutic drug monitoring in immunosuppression and transplantation.
Who uses CPT code 80180?
CPT 80180 is used by Pathology, Transplant Surgery, Rheumatology. Monitors mycophenolic acid (mycophenolate metabolite) levels in transplant recipients for optimal immunosuppression and reduced rejection risk.
When is CPT 80180 used?
Monitors mycophenolic acid (mycophenolate metabolite) levels in transplant recipients for optimal immunosuppression and reduced rejection risk.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.